119 related articles for article (PubMed ID: 32253794)
1. Structures and dynamics of DNA complexes of the desmethyl analog of the cytotoxin MLN944: Insights into activity when a methyl isn't futile.
Serobian A; Pracey CP; Thomas DS; Denny WA; Ball GE; Wakelin LPG
J Mol Recognit; 2020 Aug; 33(8):e2843. PubMed ID: 32253794
[TBL] [Abstract][Full Text] [Related]
2. The solution structure of bis(phenazine-1-carboxamide)-DNA complexes: MLN 944 binding corrected and extended.
Serobian A; Thomas DS; Ball GE; Denny WA; Wakelin LP
Biopolymers; 2014 Nov; 101(11):1099-113. PubMed ID: 24898663
[TBL] [Abstract][Full Text] [Related]
3. Novel DNA bis-intercalation by MLN944, a potent clinical bisphenazine anticancer drug.
Dai J; Punchihewa C; Mistry P; Ooi AT; Yang D
J Biol Chem; 2004 Oct; 279(44):46096-103. PubMed ID: 15317822
[TBL] [Abstract][Full Text] [Related]
4. Biological characterization of MLN944: a potent DNA binding agent.
Sappal DS; McClendon AK; Fleming JA; Thoroddsen V; Connolly K; Reimer C; Blackman RK; Bulawa CE; Osheroff N; Charlton P; Rudolph-Owen LA
Mol Cancer Ther; 2004 Jan; 3(1):47-58. PubMed ID: 14749475
[TBL] [Abstract][Full Text] [Related]
5. Kinetic studies of the binding of acridinecarboxamide topoisomerase poisons to DNA: implications for mode of binding of ligands with uncharged chromophores.
Wakelin LP; Adams A; Denny WA
J Med Chem; 2002 Feb; 45(4):894-901. PubMed ID: 11831901
[TBL] [Abstract][Full Text] [Related]
6. Novel DNA Bis-Intercalator XR5944 as a Potent Anticancer Drug-Design and Mechanism of Action.
Buric AJ; Dickerhoff J; Yang D
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299405
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of 9-amino-N-[2-(4-morpholinyl)ethyl]-4-acridinecarboxamide bound to d(CGTACG)2: implications for structure-activity relationships of acridinecarboxamide topoisomerase poisons.
Adams A; Guss JM; Denny WA; Wakelin LP
Nucleic Acids Res; 2002 Feb; 30(3):719-25. PubMed ID: 11809884
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the topoisomerase II poison 9-amino-[N-(2-dimethylamino)ethyl]acridine-4-carboxamide bound to the DNA hexanucleotide d(CGTACG)2.
Adams A; Guss JM; Collyer CA; Denny WA; Wakelin LP
Biochemistry; 1999 Jul; 38(29):9221-33. PubMed ID: 10413496
[TBL] [Abstract][Full Text] [Related]
9. The antiproliferative agent MLN944 preferentially inhibits transcription.
Byers SA; Schafer B; Sappal DS; Brown J; Price DH
Mol Cancer Ther; 2005 Aug; 4(8):1260-7. PubMed ID: 16093442
[TBL] [Abstract][Full Text] [Related]
10. In vitro assessment of novel transcription inhibitors and topoisomerase poisons in rhabdomyosarcoma cell lines.
Wolf SJ; Wakelin LP; He Z; Stewart BW; Catchpoole DR
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1059-69. PubMed ID: 19277661
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling study of intercalation complexes of tricyclic carboxamides with d(CCGGCGCCGG)₂ and d(CGCGAATTCGCG)₂.
Varvaresou A; Iakovou K
J Mol Model; 2011 Aug; 17(8):2041-50. PubMed ID: 21153908
[TBL] [Abstract][Full Text] [Related]
12. 1H NMR studies of the bis-intercalation of a homodimeric oxazole yellow dye in DNA oligonucleotides.
Johansen F; Jacobsen JP
J Biomol Struct Dyn; 1998 Oct; 16(2):205-22. PubMed ID: 9833661
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of a 2:1 complex of anticancer drug XR5944 with TFF1 estrogen response element: insights into DNA recognition by a bis-intercalator.
Lin C; Mathad RI; Zhang Z; Sidell N; Yang D
Nucleic Acids Res; 2014 May; 42(9):6012-24. PubMed ID: 24711371
[TBL] [Abstract][Full Text] [Related]
14. Acridinecarboxamide topoisomerase poisons: structural and kinetic studies of the DNA complexes of 5-substituted 9-amino-(N-(2-dimethylamino)ethyl)acridine-4-carboxamides.
Adams A; Guss JM; Collyer CA; Denny WA; Prakash AS; Wakelin LP
Mol Pharmacol; 2000 Sep; 58(3):649-58. PubMed ID: 10953060
[TBL] [Abstract][Full Text] [Related]
15. Solution conformation of the (-)-cis-anti-benzo[a]pyrenyl-dG adduct opposite dC in a DNA duplex: intercalation of the covalently attached BP ring into the helix with base displacement of the modified deoxyguanosine into the major groove.
Cosman M; Hingerty BE; Luneva N; Amin S; Geacintov NE; Broyde S; Patel DJ
Biochemistry; 1996 Jul; 35(30):9850-63. PubMed ID: 8703959
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of a DNA complex with the fluorescent bis-intercalator TOTO determined by NMR spectroscopy.
Spielmann HP; Wemmer DE; Jacobsen JP
Biochemistry; 1995 Jul; 34(27):8542-53. PubMed ID: 7612596
[TBL] [Abstract][Full Text] [Related]
17. DNA targeted platinum complexes: synthesis, cytotoxicity and DNA interactions of cis-dichloroplatinum(II) complexes tethered to phenazine-1-carboxamides.
Perrin LC; Prenzler PD; Cullinane C; Phillips DR; Denny WA; McFadyen WD
J Inorg Biochem; 2000 Jul; 81(1-2):111-7. PubMed ID: 11001439
[TBL] [Abstract][Full Text] [Related]
18. Differential DNA recognition by the enantiomers of 1-Rh(MGP)2 phi: a combination of shape selection and direct readout.
Franklin SJ; Barton JK
Biochemistry; 1998 Nov; 37(46):16093-105. PubMed ID: 9819202
[TBL] [Abstract][Full Text] [Related]
19. Phenazine-1-carboxamides: structure-cytotoxicity relationships for 9-substituents and changes in the H-bonding pattern of the cationic side chain.
Gamage SA; Rewcastle GW; Baguley BC; Charlton PA; Denny WA
Bioorg Med Chem; 2006 Feb; 14(4):1160-8. PubMed ID: 16216514
[TBL] [Abstract][Full Text] [Related]
20. Bis(phenazine-1-carboxamides): structure-activity relationships for a new class of dual topoisomerase I/II-directed anticancer drugs.
Spicer JA; Gamage SA; Rewcastle GW; Finlay GJ; Bridewell DJ; Baguley BC; Denny WA
J Med Chem; 2000 Apr; 43(7):1350-8. PubMed ID: 10753472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
